Natalie Dickson, MD

From the Field

Care Coordination Between Prescribers and the Specialty Pharmacy for Multiple Myeloma: Qualitative Insights Into Designing a Quality Improvement Program for Multisite Community Oncology Practices

08/19/2020

Stacey W McCullough, PharmD

David Blaisdell, BA

Jonathan K Kish, PhD, MPH

JaLyna Laney, RN

Tom Valuck, MD, JD

Natalie Dickson, MD

Jesus G Berdeja, MD

Jeffrey F Patton, MD

Ronda Copher, PhD

Annette Powers, PharmD, MBA

Abstract: It is widely recognized that the quality of medical care received in the United States is suboptimal, and poor-quality care may contribute to disparities in cancer incidence and mortality. While...

...

08/19/2020

Journal of Clinical Pathways

Research Reports

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting

02/15/2018

Casey Mason

Peter G Ellis, MD

Kathy Lokay

Amanda Barry, MPH

Natalie Dickson, MD

Ray Page, DO, PhD

Blase Polite, MD

Ravi Salgia, MD, PhD

Michael Savin, MD

Corey Shamah, MD

Mark A Socinski, MD

Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC), there...

...

02/15/2018

Journal of Clinical Pathways